Published December 2019
| Version v1
Journal article
Safety and Feasibility of Performing Pericardiocentesis on Patients with Significant Pulmonary Hypertension
Creators
- 1. Section of Interventional Cardiology, MedStar Washington Hospital Center, 110 Irving Street NW, Washington, DC 20010, United States of America (United States)
- 2. Department of Medicine, MedStar Georgetown University Hospital, 3800 Reservoir Road, Washington, DC 20011, United States of America (United States)
- 3. MedStar Heart & Vascular Institute, MedStar Washington Hospital Center, 110 Irving Street NW, Washington, DC 20010, United States of America (United States)
Description
Pericardial effusion (PE) is a complication of pulmonary hypertension (PHT) and, specifically, pulmonary arterial hypertension (PAH), that confers a worse prognosis. The safety of performing pericardiocentesis in patients with PHT has not been established. We aimed to assess the safety and feasibility of performing pericardiocentesis in patients with significant PHT.
Additional details
Identifiers
- DOI
- 10.1016/j.carrev.2019.09.022;
- PII
- S1553838919306475;
Publishing Information
- Journal Title
- Cardiovascular Revascularization Medicine (Print)
- Journal Volume
- 20
- Journal Issue
- 12
- Journal Page Range
- p. 1090-1095
- ISSN
- 1553-8389
INIS
- Country of Publication
- Netherlands
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 55055837
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- HYPERTENSION; PATIENTS; POLYCYCLIC AROMATIC HYDROCARBONS; THERAPY
- Descriptors DEC
- AROMATICS; CARDIOVASCULAR DISEASES; DISEASES; HYDROCARBONS; MEDICINE; ORGANIC COMPOUNDS; SYMPTOMS; VASCULAR DISEASES
Optional Information
- Copyright
- Copyright (c) 2019 Elsevier Inc. All rights reserved.